BridgeBio's shot at entering a competitive market for a rare heart condition narrowed Monday after a "baffling" result in a phase 3 clinical trial where placebo patients bested those who received the treatment in a walk test.
Prevailing theories posit plaques in the brain cause Alzheimer’s disease. New UC Riverside research instead points to cells’ slowing ability to clean themselves as the likely cause of unhealthy brain buildup.
Over the past two decades there has been a significant increase in the number of adults in the United States with small fiber neuropathy, but in many cases, no cause can be determined.